U.S. Construction Stock News

Mobileye Global (MBLY) is making headlines after the European Union moved to partially pause its free trade agreement with Israel in response to ongoing tensions in the region. This matters for investors because Mobileye, an Israel-based innovator supplying advanced driver-assistance systems, counts major European automakers like Volkswagen, BMW, and Stellantis among its key clients. The prospect of new tariffs or changing trade conditions introduces additional risk to Mobileye’s revenue...

Earlier this month, Arcutis Biotherapeutics announced the submission of a supplemental New Drug Application to the FDA seeking to expand ZORYVE cream 0.3% approval for use in treating plaque psoriasis in children as young as two years old, supported by favorable clinical study data. If approved, ZORYVE would become the first and only topical PDE4 inhibitor indicated for this age group, highlighting a potential expansion in the pediatric plaque psoriasis treatment market. We'll examine how...

Marzetti (MZTI) is attracting fresh attention after a recent analysis spotlighted its Return On Capital Employed (ROCE) at 21%, putting it far ahead of the food industry’s 10% average. What is especially interesting is that Marzetti has managed to grow the capital it uses by 26% over the last five years without sacrificing these hefty returns. This signals that management is finding places to redeploy profits for strong growth over the long haul. This kind of performance tends to get...

If you are watching ResMed (RMD) right now, you know there has been a flurry of activity. The company recently unveiled its Global Sleep Institute at the World Sleep Congress, a move aimed at rallying clinicians, researchers, and policymakers to tackle sleep health problems on a global scale. Pair that with the acquisition of VirtuOx, which adds at-home diagnostic muscle, and there is a clear message: ResMed is leaning into innovation and broadening its reach in digital respiratory...

If you have been watching Entegris (ENTG) lately, you might have noticed the stock’s recent ups and downs do not seem to be tied to any dramatic news or game-changing announcements. Sometimes, it is the absence of a clear catalyst that gets investors wondering whether there is something under the surface, or if the market is simply taking a breather. For long-term shareholders and new investors alike, these calm stretches can actually spark the biggest debates about what happens next. Over...

If you have been watching Scholar Rock Holding (SRRK), you know investors are buzzing as the company gears up for a potential U.S. launch of apitegromab, their lead drug candidate. As the first and only muscle-targeted therapy to deliver real, statistically significant functional improvement in spinal muscular atrophy, apitegromab holds promise for a rare but challenging disease. The build-up to a possible regulatory green light and mounting optimism about the drug’s commercial chance is...

If you have been keeping an eye on Youlife Group (NasdaqCM:YOUL) lately, it is hard to miss the excitement building around its stock. After announcing standout earnings for the first half of 2025, including a sizeable jump in both revenue and profit, Youlife also sealed the deal on a joint venture with Beijing Galbot Co., Ltd. This move, together with plans to expand its reach across HR, AI, and vocational training, has investors buzzing about what could come next for the company. The impact...

In recent months, several insiders at LeMaitre Vascular, including Chairman & CEO George LeMaitre, sold significant amounts of company stock, with no insider purchases on record and total insider ownership now at 7.9%. This pattern of ongoing insider selling, particularly involving the CEO's US$8.2 million transaction, raises questions among investors about leadership’s confidence in the company’s current valuation. Given the recent series of insider stock sales, we'll explore how this...

Nvidia (NVDA) has been on the minds of many investors lately, even without a major triggering event driving headlines. Whenever a stock as widely followed as Nvidia sees active trading or nudges in price, it naturally prompts the classic questions: are we witnessing an early signal of something bigger under the surface, or is this simply part of the regular ebb and flow of a market leader? Looking at the bigger picture, Nvidia remains firmly in the spotlight. The company’s stock climbed...

If you’ve been watching Valmont Industries (VMI), you know the company just crossed another major milestone. Investors are buzzing as shares recently notched a new 52-week high, fueled by upbeat earnings and steady revenue growth. The most interesting part is that Valmont’s long history of exceeding earnings expectations is now amplified by its central role in supplying infrastructure for the booming AI data center market, a space that has everyone in tech and industrials talking. Stepping...

Howmet Aerospace recently reported second quarter results, posting adjusted EPS of US$0.91 and revenue of US$2.1 billion, both of which surpassed analysts' forecasts. This outperformance, largely fueled by growth in commercial aerospace and robust defense sector demand, underscores Howmet's strong position as upcoming defense budget allocations are anticipated to further support business growth. We'll explore how Howmet's stronger-than-expected quarterly results and rising aerospace demand...

If you are watching WisdomTree (WT) after their recent record-breaking announcement, you are not alone. The company just reported assets under management topping $131 billion, powered by net inflows and double-digit organic growth since January. This milestone comes alongside the launch of their blockchain-native Private Credit and Alternative Income Digital Fund, signaling a fresh approach to opening up traditionally exclusive markets to a wider investor base. These updates follow a very...

If you have been watching aTyr Pharma (ATYR), you know the stock has been turning heads lately, and for good reason. The company is on the brink of a key moment as results from the pivotal Phase 3 EFZO-FIT trial for its lead candidate, efzofitimod, are due out any day now. This treatment is aimed at pulmonary sarcoidosis, a rare and challenging lung disease that currently lacks reliable therapies. The market seems to be anticipating something significant, with visible excitement around the...

If you spotted the recent move in Paramount Group (NYSE:PGRE), you might be wondering what’s going on under the hood. There wasn’t any major announcement or headline event driving trading this week. Sometimes stocks swing without obvious cause, catching investors a bit off guard. When you’re on the sidelines watching a real estate name like Paramount Group shift higher or lower, it’s natural to ask whether there’s a deeper story or just routine market noise. Looking at Paramount Group’s...

In recent days, Corning drew industry attention after Apple CEO Tim Cook visited its Kentucky facility, highlighting the company's integral role in supplying specialized glass for Apple devices. This visit underscores Corning's deep ties to leading technology players while its Optical Communications division continues to experience very large year-over-year growth driven by AI-related infrastructure demand. We'll now explore how surging demand for fiber optics to support AI data centers...

If you have been keeping an eye on cybersecurity stocks lately, CyberArk Software has likely caught your attention. It is no secret the company has been on a remarkable run, with shares gaining 38.9% so far this year and an eye-popping 71.7% in the past twelve months. Even stretching back five years, CyberArk’s stock is up more than 377.3%. This performance has outpaced most tech peers and reflects investor confidence in both its platform and the ever-increasing demand for robust digital...

CleanSpark, Inc. recently announced a series of executive leadership and organizational changes, including new roles and expanded responsibilities for several senior leaders as approved by its Board of Directors effective September 4, 2025. This realignment highlights a greater emphasis on operational execution and growth in bitcoin mining, with leaders now overseeing core functions such as financial strategy, infrastructure expansion, and technological innovation. We'll examine how...

IHS Côte d’Ivoire recently entered a Memorandum of Understanding with NABU Global Inc. to promote early childhood literacy, rolling out a 12-month digital and print program targeting 100,000 children across more than 30 schools. This collaboration aims to support sustainable development and education in Côte d’Ivoire, equipping educators to foster reading habits and encourage girls in STEM fields. Next, we'll consider how IHS Holding's financial outperformance and literacy partnership...

Shares of UWM Holdings recently moved higher after investors reacted to fresh U.S. economic data suggesting the Federal Reserve may consider an interest rate cut, following a surge in jobless claims to the highest level since 2021. This development is especially relevant for UWM Holdings as lower interest rates could encourage increased mortgage borrowing and refinancing, benefiting mortgage lenders in a potentially cooling labor market. We'll explore how heightened expectations of Fed rate...

AXIS Capital Holdings recently reported a return on equity of 14%, in line with the industry, and a five-year earnings growth rate of 38%, far ahead of the sector average. The company's focus on reinvesting profits has supported this earnings expansion, though analysts now express caution over the pace of future growth. To assess the impact on AXIS's outlook, we'll consider how its efficient capital use could reinforce the existing investment narrative. We've found 18 US stocks that are...

Floor & Decor Holdings recently held the grand opening of a new warehouse-format store and design center in Lancaster, California, expanding its footprint to over 250 locations across 38 states with a local team of 33 associates. This expansion highlights the company's ongoing commitment to serving new markets and underscores its approach to nationwide growth in the hard-surface flooring retail sector. We'll explore how this latest store opening bolsters Floor & Decor's footprint and impacts...

Centessa Pharmaceuticals recently presented at high-profile industry events, including the World Sleep Congress in Singapore and the Morgan Stanley Global Healthcare Conference in New York, showcasing its lead asset ORX750. Heightened analyst interest and discussion at these events have reinforced expectations that upcoming Phase 2a data for ORX750 could be a significant milestone for the company. We'll explore how anticipation of clinical trial results for ORX750 is shaping Centessa’s...

AZZ Inc. recently achieved a new 52-week high, following several quarters of earnings surpassing analyst expectations and recognition for both growth and value characteristics. Analysts have highlighted AZZ as undervalued compared to industry peers, and growing investor interest has coincided with a positive outlook for revenue and earnings. Next, we will explore how AZZ's record of earnings surprises could influence its current investment narrative and future growth trajectory. The best AI...

ICON plc recently announced that CEO Dr. Steve Cutler has retired, with former Chief Operating Officer Barry Balfe appointed as the new Chief Executive Officer and to the Board effective October 1, 2025, while Dr. Cutler remains on the Board as a non-executive director to assist in the leadership transition. This internal succession brings an executive with deep clinical research organization experience to the helm, signaling continuity in ICON’s operational and industry approach during a...